FDA Approves Merck's New Live Ebola Vaccine Which It Says Can Shed and Cause Immunosuppression

Merck has received the FDA's fast-tracked approval of a live, genetically modified Ebola vaccine which, according to its vaccine insert, can cause a novel new form of Ebola-type infection, resulting in immunosuppression and possible shedding of live virus to others.
[Source: www.greenmedinfo.com] [ Comments ] [See why this is trending]
[Source: www.greenmedinfo.com] [ Comments ] [See why this is trending]
Comments